Navigation Links
Echo Therapeutics Reports Symphony™ tCGM System Ahead of Schedule
Date:2/17/2011

ho Therapeutics is developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system for patients with diabetes and for use in hospital critical care units. Echo is also developing its needle-free Prelude SkinPrep System as a platform technology for enhanced skin permeation for delivery of topical pharmaceuticals.

Cautionary Statement Regarding Forward Looking StatementsThe statements in this press release that are not historical facts may constitute forward-looking statements that are based on current expectations and are subject to risks and uncertainties that could cause actual future results to differ materially from those expressed or implied by such statements. Those risks and uncertainties include, but are not limited to, risks related to regulatory approvals and the success of Echo's and its partners' ongoing studies, including the efficacy of Echo's Symphony tCGM and Prelude SkinPrep Systems, the failure of future development and preliminary marketing efforts related to Echo's Symphony tCGM and Prelude SkinPrep Systems, Echo's ability to secure additional commercial partnering arrangements, risks and uncertainties relating to Echo's and its partners' ability to develop, market and sell diagnostic and transdermal drug delivery products based on its skin permeation platform technologies, including the Symphony tCGM and Prelude SkinPrep Systems, the availability of substantial additional equity or debt capital to support its research, development and product commercialization activities, and the success of its research, development, regulatory approval, marketing and distribution plans and strategies, including those plans and strategies related to its Symphony tCGM and Prelude SkinPrep Systems. These and other risks and uncertainties are identified and described in more detail in Echo's filings with the Securities and Exchange Commission, including, without limitation, its annual report on Form 10-K f
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Orexigen® Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
2. Prime Therapeutics Vice President of Specialty Pharmacy Solutions Speaks at 16th Annual PBMI Drug Benefit Conference
3. Echo Therapeutics Announces Appointments to Board of Directors
4. Tarsa Therapeutics Completes Phase III Trial of its Oral Calcitonin for Treatment of Postmenopausal Osteoporosis and Initiates Phase II Trial in Osteoporosis Prevention
5. Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End 2010 Financial Results on February 16
6. Cephalon Signs Option Agreement to Acquire Assets from Alba Therapeutics
7. Amicus Therapeutics Initiates Phase 2 Clinical Trial Evaluating Amigal™ Co-administered with Enzyme Replacement Therapy
8. Prime Therapeutics President and CEO Eric Elliott Presents Keynote Address at 2011 PCMA Managed Markets Educational Forum
9. NewCardio Study of QTinno Accuracy Selected for Presentation at the National Scientific Meeting of the American Society of Clinical Pharmacology and Therapeutics
10. DSM and NKT Therapeutics Sign Contract for Lead Product Development and Manufacture
11. JumpStart Ventures and Cleveland Clinic Invest in SironRX Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... May 26, 2015  Array BioPharma Inc. (Nasdaq: ... Executive Officer, Ron Squarer , will present ... New York City. The public is welcome to participate ... Array BioPharma website.Event: Jefferies 2015 Global Healthcare ConferencePresenter:Ron ... Eastern Time Webcast: www.arraybiopharma.com  About Array BioPharma ...
(Date:5/26/2015)... May 26, 2015 Sanomedics, Inc. (OTC: SIMH) ... has expanded into the fast growing behavioral health sector ... is a developmental stage, Software as a Services (SaaS) ... addiction treatment service and care centers. ... to enter the nascent behavioral health sector where the ...
(Date:5/26/2015)... , May 26, 2015 Boston Scientific Corporation ... Goldman Sachs 36 th Annual Global Healthcare Conference on ... Dan Brennan , executive vice president ... president, Investor Relations, will participate in a 35-minute question and ... at approximately 10 a.m. PT. A live webcast ...
Breaking Medicine Technology:Sanomedics Targeting Behavioral Health and Electronic Health Records with Strategic Acquisition of Zen Charts 2Sanomedics Targeting Behavioral Health and Electronic Health Records with Strategic Acquisition of Zen Charts 3Boston Scientific To Participate In The Goldman Sachs 36th Annual Global Healthcare Conference 2
... of once-daily TMC278 in ... treatment-naive adults with HIV-1 -, ... from Tibotec,Pharmaceuticals Ltd. provides additional information on the safety ... inhibitor (NNRTI), as part of HIV,combination therapy in treatment-naive ...
... CAMBRIDGE, Mass., Aug. 5 Tolerx, Inc., a,biopharmaceutical ... novel,therapies for the treatment of immune-mediated diseases, announced ... version of TRX1,MTRX1011A, an anti-CD4 monoclonal antibody, into ... patients. The clinical trial is evaluating the,safety and ...
Cached Medicine Technology:Ninety-Six Week Data on Tibotec Investigational NNRTI, TMC278, Presented at AIDS 2008 2Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 2Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 3
(Date:5/26/2015)... (PRWEB) May 26, 2015 It was ... community foundation in Colorado. On Wednesday, May 13, The ... in a new era of community-based giving with its ... “Our Future in the Making,” the event celebrated the ... Denver Foundation to mobilize resources for good. , “If ...
(Date:5/26/2015)... Synthetic cannabinoids attempt to mimic ... published by International Business Times on ... and black mamba) causes unpredictable medical and psychiatric ... make it nearly impossible for medical doctors to ... substance due to the frequency in which the ...
(Date:5/26/2015)... Norcross, GA (PRWEB) May 26, 2015 ... partnered with Airbus Defence and Space in a new ... data and software for use in the development of ... Hexagon Content Program, this partnership combines optical satellite data ... offerings. Intended to tear down the walls between geospatial ...
(Date:5/26/2015)... NY (PRWEB) May 26, 2015 Award-winning travel ... a good cause. "The photography show will connect viewers to ... their lives.” For the last five years, Raul has traveled ... convey the notion that we are not bounded by our ... language spoken in Raul’s native country, Bolivia. The photo gallery ...
(Date:5/26/2015)... 2015 On June 4, 2015, ... online broadcast at 6:00pm PST/9:00 pm EST. This ... Alice Branton welcomes the public to attend and invite ... profound knowledge, transformation and enlightenment. The webinar is ... previous knowledge, experience or other prerequisites are required. , ...
Breaking Medicine News(10 mins):Health News:Celebrating "Our Future in the Making" 2Health News:Celebrating "Our Future in the Making" 3Health News:Synthetic Cannabinoids Can Cause Psychotic Episodes; Doctors at a Loss for Treatment 2Health News:Synthetic Cannabinoids Can Cause Psychotic Episodes; Doctors at a Loss for Treatment 3Health News:Hexagon Geospatial and Airbus Defense Establish Partnership 2Health News:Hexagon Geospatial and Airbus Defense Establish Partnership 3Health News:A Photographer & Two Educational Organiazations Join to Make a Difference in Our Youth 2Health News:The Human Wellness Company Trivedi Master Wellness™ Opens a Complimentary Transformational Community Call to the Public on June 4, 2015 2Health News:The Human Wellness Company Trivedi Master Wellness™ Opens a Complimentary Transformational Community Call to the Public on June 4, 2015 3
... from eating fish to krill (shrimp-like marine invertebrate animals) ... and whales, ancient eggshell fragments reveal. ... Carolina in Wilmington, and William Patterson of the University ... removed krill-eating predators, the penguins exploited the resulting shrimp ...
... time, researchers have shown that plant growth is regulated ... ,Using time-lapse photography, post-doctoral researcher Kazunari Nozue, ... the University of Lausanne, Switzerland, found that the shoots ... a day. They claimed that the timing of that ...
... first after restoring the fertility of a woman made ... ,The gynaecologist, Jacques Donnez, said he had successfully ... at the Cliniques Universitaires Saint-Luc in Brussels. ... graft, the patient continues to menstruate regularly. Her ovarian ...
... the stone that kills two vices. ,United States FDA-approved smoking ... handed out to alcoholics as well . , The ... used quite successfully by smokers , was tested to reveal the ... ,Says Selena Bartlett, a University of California, San Francisco ...
... ESMO Conference Lugano this week show that the drug, ... a marker of cancer activity, and shrank tumors in ... also in patients who had previously been treated with ... have continued to grow despite medical or surgical castration, ...
... in the July issue of the journal Cancer Cell, ... in development of acute promyelocytic leukemia (APL) and identifies ... its variant forms. ,Results from two new ... events that cause a deadly type of leukemia.,APL is ...
Cached Medicine News:Health News:Penguins Altered Diet When Humans Began Hunting Whales and Seals 2Health News:Two In One Drug For Smokers And Drinkers 2Health News:Hormone Inhibitor in Prostate Cancer Treatment 2Health News:Insights into Acute Promyelocytic Leukemia 2Health News:Insights into Acute Promyelocytic Leukemia 3
Non-reflective black anodized aluminum. Selection of five pin hole sizes (0.8 mm to 1.5 mm). Overall length: 4.0 inches....
4 mm x 4 mm downward biting jaws, curved right, length of shaft 115 mm, overall length 9.3 inches....
Right side cutting....
20 mm. Plastic, methylmethacrylate. Supplied sterile....
Medicine Products: